Bristol-Myers Squibb buy Daiwa Capital Markets
Start price
13.11.24
/
50%
€55.26
Target price
13.11.25
-
Performance (%)
-24.25%
End price
14.11.25
€41.86
Summary
This prediction ended on 14.11.25 with a price of €41.86. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -24.25%. Dividends of €0.60 are taken into consideration when calculating the performance. Daiwa_Capital_Market has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 3.575% | 3.575% | 38.175% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Daiwa_Capital_Market for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Daiwa_Capital_Market gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Daiwa_Capital_Market for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€59.00
28.06.23
28.06.23
€64.04
28.06.24
28.06.24
-33.56%
29.06.24
29.06.24
